Compare Alphabet Inc Class A (GOOGL) vs Ionis Pharmaceuticals Inc. Common Stock (IONS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Alphabet Inc Class A vs Ionis Pharmaceuticals Inc. Common Stock — how do they compare? Alphabet Inc Class A trades at $344.59 (market cap $4.23T), while Ionis Pharmaceuticals Inc. Common Stock trades at $43.32 (market cap $7.10B). The key difference: Alphabet Inc Class A is far larger — about 595.8× Ionis Pharmaceuticals Inc. Common Stock's market cap, and Alphabet Inc Class A pays a 0.25% dividend while Ionis Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Alphabet Inc Class A for 86 Days and Ionis Pharmaceuticals Inc. Common Stock for 0 Days on average.
| GOOGL | IONS | |
|---|---|---|
Market Cap | $4.23T | $7.10B |
Volume | 27,871,114 | 2,027,457 |
Sector | Media | Health |
52-Week High | $402.62 | $86.50 |
52-Week Low | $250.46 | $42.38 |
Typical Hold Time | 86 Days | 0 Days |
Enterprise Value | $4.12T | $6.66B |
Dividend Yield | 0.25% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Alphabet (GOOGL) trades at $353.78, up 0.3% today, with a bullish technical outlook as moving averages signal strength and the stock tests resistance near $356. Fundamentally, the company reported robust earnings beats in recent quarters, with Q2 2026 EPS of $9.11 exceeding expectations, while revenue grew to $402.84B in 2025. Strong profitability metrics include a net income margin of 54.77% and ROE of 49.55%, supported by positive cash flow trends.
The outlook remains positive given analyst consensus favoring a buy rating (86.75%) and a price target of $430.96, implying significant upside. Key risks include competitive pressures in AI and regulatory scrutiny, but Alphabet's diversified revenue streams and AI investments position it for growth. Investors should weigh high valuation multiples against earnings momentum.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Alphabet Inc Class A
Alphabet, the parent company of Google, earns nearly 90% of its revenue from Google services, mainly through advertising. Other revenue comes from subscriptions (YouTube TV, YouTube Music), platform sales (Play Store purchases), and devices (Pixel, Chromebooks, Chromecast). Google Cloud contributes around 10%, while investments in self-driving cars (Waymo), health (Verily), and internet access (Google Fiber) make up the rest.
Read more on GOOGL →About Ionis Pharmaceuticals Inc. Common Stock
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →
